enGene Therapeutics (ENGN) Current Taxes (2022 - 2025)

enGene Therapeutics (ENGN) posted quarterly Current Taxes of $19000.0 for Q4 2025, down 96.65% quarter-over-quarter from $567000.0 in Q3 2025.

enGene Therapeutics (ENGN) Current Taxes (2022 - 2025) Analysis & Trends

enGene Therapeutics (ENGN) has reported Current Taxes for 4 consecutive years, with $19000.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Current Taxes changed N/A year-over-year to $19000.0; the TTM figure through Oct 2025 stood at $19000.0 (changed N/A YoY), while the FY2025 annual figure was $19000.0, changed N/A from the prior year.
Current Taxes declined to $19000.0 in Q4 2025 per ENGN's latest filing, from $567000.0 in the prior quarter.
Across five years, Current Taxes topped out at $567000.0 in Q3 2025 and bottomed at $9000.0 in Q1 2024.
Historically, Current Taxes has averaged $137750.0 across 4 years, with a median of $34500.0 in 2023.
Annual changes were most pronounced in 2023 — Current Taxes surged 77.27% — and 2025, when it jumped 993.33%.
enGene Therapeutics' Current Taxes stood at $22000.0 in 2022, then soared by 77.27% to $39000.0 in 2023, then retreated by 23.08% to $30000.0 in 2024, then sank by 36.67% to $19000.0 in 2025.
Business Quant data shows ENGN's Current Taxes at $19000.0 in Q4 2025, $567000.0 in Q3 2025, and $328000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	enGene Therapeutics	124.11 Mn	124.11 Mn	-	-

Download Data